Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma.
Giembycz
M A
MA
Department of Thoracic Medicine, Royal Brompton National Heart and Lung Institute, London, U.K.
Dent
G
G
D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases / Q000037:antagonists & inhibitors*; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors*
D007527:Isoenzymes; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases